Skip to main content

Table 2 Differences in immunosuppressant use and the pregnancy outcome

From: Effect of deflazacort on pregnancy outcome in kidney transplant patients: should we change the immunosuppressant before conception?

   Non-pregnant (n = 19) Clinical pregnancy (n = 21) P value
     0.73
Regimen CI 3 (15.8%) 6 (28.6%)  
CI + ST + AP 7 (36.8%) 5 (23.8%)  
CI + ST 8 (42.1%) 9 (42.9%)  
CI + AP 1 (5.3%) 1 (4.8%)  
Immunosuppressant use CyA 5 (26.3%) 9 (42.9%) 0.27
  TAC 13 (68.4%) 12 (57.1%) 0.46
  DFZ 10 (52.6%) 2 (9.5%) 0.003
  Pred 8 (42.1%) 13 (61.9%) 0.21
  Aza 5 (26.3%) 2 (9.5%) 0.16
  MMF 4 (21.1%) 4 (19%) 0.87
  1. Note: CI calcineurin inhibitor, ST steroid, AP antiproliferative drug, CyA cyclosporine, TAC tacrolimus, DFZ deflazacort, Pred predinosolone, Aza azathioprine, MMF mycophenolate mofetil